| | | | | |
CTKB Cytek Biosciences, Inc. Common Stock | $4,8100 | +3,22% | $621,31M | $819,58K | |
FDMT 4D Molecular Therapeutics, Inc. Common Stock | $15,8200 | -1,74% | $620,51M | $918,66K | |
EIKN Eikon Therapeutics, Inc. Common Stock | $11,3700 | +5,77% | $619,88M | $532,76K | |
| $18,9600 | -2,82% | $619,48M | $360,49K | |
| $59,4800 | +0,63% | $618,62M | $75,23K | |
EMD Western Asset Emerging Markets Debt Fund, Inc | $10,6000 | +0,47% | $618,50M | $131,75K | |
CBNK Capital Bancorp, Inc. | $36,5400 | -0,33% | $617,08M | $72,57K | |
NRDS NerdWallet, Inc. Class A Common Stock | $9,8700 | -1,40% | $616,85M | $1,09M | |
| $71,5200 | +1,95% | $616,57M | $177,89K | |
TRAX First Tracks Biotherapeutics, Inc. Ordinary Shares | $43,0000 | +2,63% | $615,50M | $527,86K | |
CGNT Cognyte Software Ltd. Ordinary Shares | $8,5900 | -0,35% | $613,97M | $925,74K | |
BWB Bridgewater Bancshares, Inc. Common Stock | $21,6000 | +0,23% | $613,72M | $183,58K | |
VINP Vinci Compass Investments Ltd. Class A Common Shares | $9,5300 | +2,14% | $613,18M | $63,54K | |
ELMT The Elmet Group Co. Common Stock | $19,8500 | +19,08% | $612,93M | $1,74M | |
| $7,1300 | -0,42% | $611,79M | $712,62K | |
